:START_ID,:END_ID,type:TYPE,method,trigger,evidence_span,section_heading,sentence_id:int
41,42,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"4A, Table 3).Among matrix metalloproteinases, MMP 1, 3, and 10 showed significant up-regulation in flight samples compared to ground controls (12.94,2.98, and 16.85 fold respectively, p,0.05), while MMP inhibitors, TIMP 1, 2, and 3, display",Spaceflight Induces MMP-Mediated Extracellular Matrix Remodeling in Bone,65
41,43,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"4A, Table 3).Among matrix metalloproteinases, MMP 1, 3, and 10 showed significant up-regulation in flight samples compared to ground controls (12.94,2.98, and 16.85 fold respectively, p,0.05), while MMP inhibitors, TIMP 1, 2, and 3, display",Spaceflight Induces MMP-Mediated Extracellular Matrix Remodeling in Bone,65
41,44,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"4A, Table 3).Among matrix metalloproteinases, MMP 1, 3, and 10 showed significant up-regulation in flight samples compared to ground controls (12.94,2.98, and 16.85 fold respectively, p,0.05), while MMP inhibitors, TIMP 1, 2, and 3, display",Spaceflight Induces MMP-Mediated Extracellular Matrix Remodeling in Bone,65
42,43,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"4A, Table 3).Among matrix metalloproteinases, MMP 1, 3, and 10 showed significant up-regulation in flight samples compared to ground controls (12.94,2.98, and 16.85 fold respectively, p,0.05), while MMP inhibitors, TIMP 1, 2, and 3, display",Spaceflight Induces MMP-Mediated Extracellular Matrix Remodeling in Bone,65
42,44,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"4A, Table 3).Among matrix metalloproteinases, MMP 1, 3, and 10 showed significant up-regulation in flight samples compared to ground controls (12.94,2.98, and 16.85 fold respectively, p,0.05), while MMP inhibitors, TIMP 1, 2, and 3, display",Spaceflight Induces MMP-Mediated Extracellular Matrix Remodeling in Bone,65
43,44,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"4A, Table 3).Among matrix metalloproteinases, MMP 1, 3, and 10 showed significant up-regulation in flight samples compared to ground controls (12.94,2.98, and 16.85 fold respectively, p,0.05), while MMP inhibitors, TIMP 1, 2, and 3, display",Spaceflight Induces MMP-Mediated Extracellular Matrix Remodeling in Bone,65
55,56,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,", we found several genes associated with cell growth and differentiation that were altered, including Egr1, Myod1, and Fgf3 which were down-regulated (22.30, 21.61, and 21.7 fold respectively, p,0.05), while Twist1 and Fgf1 were up-regulate",Spaceflight Suppresses Pro-Osteogenic Growth and Proliferation Gene Expression in Bone,73
66,67,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"6G, Table 3).Several genes associated with cell cycle regulation were also altered in flight samples including cell cycle arrest related genes Fbxo4, Fbxo31, Btg2, and Cdkn2b (1.87, 1.74, 21.50, and 1.41 fold respectively, p,0.05), and cell",Spaceflight Induces CDKN1a/p21 but Not Trp53/p53 Expression in Bone,79
69,70,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"6G, Table 3).Several genes related to the induction of apoptosis were also altered including, Cradd, Dapk1, Fbxo3, which were up-regulated in flight samples (1.62, 1.53, and 1.48 fold respectively, p,0.01) (Fig. 6G).Hecw2, which acts to sta",Spaceflight Induces CDKN1a/p21 but Not Trp53/p53 Expression in Bone,80
75,76,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
75,77,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
75,78,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
75,79,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
75,80,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
76,77,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
76,78,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
76,79,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
76,80,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
77,78,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
77,79,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
77,80,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
78,79,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
78,80,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
79,80,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"As cell signaling promoting cell survival via phosphoinositide 3kinase (Pi3K)/protein kinase B (Akt) and cell proliferation via Mitogen Activated Protein Kinase (MAP kinase) can both be activated in response to mechano-transduction, and as ",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,85
82,83,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"5, Table 3).Several molecules associated with Ras signaling displayed alterations, including Nf1 (21.45 fold, p,0.05) and Sos1 (22.51 fold, p,0.01); however, only small changes in KRas expression was found (21.24 fold, p,0.05) (Fig.",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,86
82,84,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"5, Table 3).Several molecules associated with Ras signaling displayed alterations, including Nf1 (21.45 fold, p,0.05) and Sos1 (22.51 fold, p,0.01); however, only small changes in KRas expression was found (21.24 fold, p,0.05) (Fig.",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,86
82,85,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"5, Table 3).Several molecules associated with Ras signaling displayed alterations, including Nf1 (21.45 fold, p,0.05) and Sos1 (22.51 fold, p,0.01); however, only small changes in KRas expression was found (21.24 fold, p,0.05) (Fig.",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,86
83,84,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"5, Table 3).Several molecules associated with Ras signaling displayed alterations, including Nf1 (21.45 fold, p,0.05) and Sos1 (22.51 fold, p,0.01); however, only small changes in KRas expression was found (21.24 fold, p,0.05) (Fig.",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,86
83,85,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"5, Table 3).Several molecules associated with Ras signaling displayed alterations, including Nf1 (21.45 fold, p,0.05) and Sos1 (22.51 fold, p,0.01); however, only small changes in KRas expression was found (21.24 fold, p,0.05) (Fig.",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,86
84,85,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"5, Table 3).Several molecules associated with Ras signaling displayed alterations, including Nf1 (21.45 fold, p,0.05) and Sos1 (22.51 fold, p,0.01); however, only small changes in KRas expression was found (21.24 fold, p,0.05) (Fig.",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,86
100,101,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Analysis of NFkB transcriptional target genes involved in cell adhesion, regulation of apoptosis and growth factors and ligands including Traf1, BMP4, Egr1, p53, and MMP3 (repressor) were found to be down-regulated, indicating inhibition of",Spaceflight Alters Gene Expression That Can Interfere with Survival and Mitogenic Signal Transduction,93
143,144,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"In addition to bone, our gene expression results also show accumulation of p21 in muscle (Fig. 6) and heart tissue (A.Kumar, E.A.C. Almeida, and R.K. Globus, unpublished results).One possible mechanism for systemic expression of CDKN1a/p21 ",DISCUSSION,140
143,145,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"In addition to bone, our gene expression results also show accumulation of p21 in muscle (Fig. 6) and heart tissue (A.Kumar, E.A.C. Almeida, and R.K. Globus, unpublished results).One possible mechanism for systemic expression of CDKN1a/p21 ",DISCUSSION,140
143,146,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"In addition to bone, our gene expression results also show accumulation of p21 in muscle (Fig. 6) and heart tissue (A.Kumar, E.A.C. Almeida, and R.K. Globus, unpublished results).One possible mechanism for systemic expression of CDKN1a/p21 ",DISCUSSION,140
144,145,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"In addition to bone, our gene expression results also show accumulation of p21 in muscle (Fig. 6) and heart tissue (A.Kumar, E.A.C. Almeida, and R.K. Globus, unpublished results).One possible mechanism for systemic expression of CDKN1a/p21 ",DISCUSSION,140
144,146,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"In addition to bone, our gene expression results also show accumulation of p21 in muscle (Fig. 6) and heart tissue (A.Kumar, E.A.C. Almeida, and R.K. Globus, unpublished results).One possible mechanism for systemic expression of CDKN1a/p21 ",DISCUSSION,140
145,146,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"In addition to bone, our gene expression results also show accumulation of p21 in muscle (Fig. 6) and heart tissue (A.Kumar, E.A.C. Almeida, and R.K. Globus, unpublished results).One possible mechanism for systemic expression of CDKN1a/p21 ",DISCUSSION,140
149,150,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Although we have found no cellular evidence of increased apoptosis, several apoptosis-related genes were also upregulated in flight samples including Cradd, Dapk1, Fbxo31, Hecw2 and MAPK10 (Table 3).The expression of these genes without inc",DISCUSSION,144
149,151,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Although we have found no cellular evidence of increased apoptosis, several apoptosis-related genes were also upregulated in flight samples including Cradd, Dapk1, Fbxo31, Hecw2 and MAPK10 (Table 3).The expression of these genes without inc",DISCUSSION,144
150,151,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Although we have found no cellular evidence of increased apoptosis, several apoptosis-related genes were also upregulated in flight samples including Cradd, Dapk1, Fbxo31, Hecw2 and MAPK10 (Table 3).The expression of these genes without inc",DISCUSSION,144
152,153,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"We found message expression reductions in TGF-b2; FGF1 and 3; BMP4; Egr1; and Csf3 (Fig. 5, Table 3).Tgf-b is produced by osteoblasts and deposited in bone matrix during bone formation, and released by osteoclasts during bone resorption",DISCUSSION,147
155,156,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[66].Several additional genes associated with cell growth and differentiation including Myod1, Twist1, and Egr1 were also altered in spaceflight (Fig.",DISCUSSION,153
161,162,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Decreased Myod1 expression suggests a decrease in CDKN1a/p21 levels associated with cell differentiation, and leads us to hypothesize that the CDKN1a/p21 elevation we observe in spaceflight is independent of differentiation, and possibly in",DISCUSSION,156
167,168,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast ",DISCUSSION,160
167,169,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast ",DISCUSSION,160
167,170,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast ",DISCUSSION,160
168,169,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast ",DISCUSSION,160
168,170,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast ",DISCUSSION,160
169,170,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast ",DISCUSSION,160
172,173,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Vdr gene expression is stimulated by Ras/Raf/MAP kinase signaling through the AP-1 site on the Vdr promoter [46,70].Vitamin D has been shown to modulate NFkB activity in multiple cell types, which suggests a role for the Vitamin D receptor ",DISCUSSION,162
172,174,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Vdr gene expression is stimulated by Ras/Raf/MAP kinase signaling through the AP-1 site on the Vdr promoter [46,70].Vitamin D has been shown to modulate NFkB activity in multiple cell types, which suggests a role for the Vitamin D receptor ",DISCUSSION,162
173,174,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Vdr gene expression is stimulated by Ras/Raf/MAP kinase signaling through the AP-1 site on the Vdr promoter [46,70].Vitamin D has been shown to modulate NFkB activity in multiple cell types, which suggests a role for the Vitamin D receptor ",DISCUSSION,162
175,176,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Vdr-null mice have been shown to have decreased IkBa levels due to loss of vdr-p65 interaction affecting NFkB transcriptional activity [48].This could provide an additional mechanism for the observed inhibition of NFkB activation in our spa,DISCUSSION,163
175,177,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Vdr-null mice have been shown to have decreased IkBa levels due to loss of vdr-p65 interaction affecting NFkB transcriptional activity [48].This could provide an additional mechanism for the observed inhibition of NFkB activation in our spa,DISCUSSION,163
176,177,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Vdr-null mice have been shown to have decreased IkBa levels due to loss of vdr-p65 interaction affecting NFkB transcriptional activity [48].This could provide an additional mechanism for the observed inhibition of NFkB activation in our spa,DISCUSSION,163
178,179,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The MAP kinase-ERK pathway is also known to activate the transcription factor Sox9 [71], which is a regulatory factor required for chondrocyte differentiation",DISCUSSION,164
178,180,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The MAP kinase-ERK pathway is also known to activate the transcription factor Sox9 [71], which is a regulatory factor required for chondrocyte differentiation",DISCUSSION,164
179,180,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The MAP kinase-ERK pathway is also known to activate the transcription factor Sox9 [71], which is a regulatory factor required for chondrocyte differentiation",DISCUSSION,164
182,183,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[72].Activation of Sox9 by p38-MAP kinase signaling results in chondrocyte growth and differentiation while depression of Sox9 transcription results in cartilage degeneration and osteo-arthritis [55,73].Additionally, Sox9 is important for e",DISCUSSION,165
182,184,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[72].Activation of Sox9 by p38-MAP kinase signaling results in chondrocyte growth and differentiation while depression of Sox9 transcription results in cartilage degeneration and osteo-arthritis [55,73].Additionally, Sox9 is important for e",DISCUSSION,165
182,185,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[72].Activation of Sox9 by p38-MAP kinase signaling results in chondrocyte growth and differentiation while depression of Sox9 transcription results in cartilage degeneration and osteo-arthritis [55,73].Additionally, Sox9 is important for e",DISCUSSION,165
183,184,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[72].Activation of Sox9 by p38-MAP kinase signaling results in chondrocyte growth and differentiation while depression of Sox9 transcription results in cartilage degeneration and osteo-arthritis [55,73].Additionally, Sox9 is important for e",DISCUSSION,165
183,185,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[72].Activation of Sox9 by p38-MAP kinase signaling results in chondrocyte growth and differentiation while depression of Sox9 transcription results in cartilage degeneration and osteo-arthritis [55,73].Additionally, Sox9 is important for e",DISCUSSION,165
184,185,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"[72].Activation of Sox9 by p38-MAP kinase signaling results in chondrocyte growth and differentiation while depression of Sox9 transcription results in cartilage degeneration and osteo-arthritis [55,73].Additionally, Sox9 is important for e",DISCUSSION,165
186,187,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Rps6kb1, a down-stream effector of the Pi3K/Akt/mTOR pathway, was also down-regulated in spaceflight (Table 3), and is involved in cell proliferation through the activation of protein synthesis by Eif4e and inhibition of apoptosis through p",DISCUSSION,166
197,198,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The pelvic ischium and proximal femur were fixed in 4% paraformaldehyde for 24 h at 4uC, washed twice with PBS, and stored in PBS at 4uC.The pelvic ischium was used for microcomputed tomography (mCT) and nano-computed tomography (nCT), whil",Animals,189
210,211,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"For analysis, a selected region of 4.89 mm (720 slices), starting from 5 slices proximal to caudal apex of the obturator foramen through ischial tuberosity (Fig. 1A), was analyzed using CTan software (Skyscan v1.10.9.0).A global binarizatio",Micro-Computed Tomography (mCT),197
213,214,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,These images were loaded into CTvox 3D visualization program (Skyscan v1.0.or479) for a qualitative comparison of bone thickness between flight and ground control groups.,Micro-Computed Tomography (mCT),202
219,220,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Ischia from seven ground control and eight spaceflight mice were fixed in 4% paraformaldehyde and stored in PBS, prior to cutting 30 mm thick cortical bone sections using single-use steel histology blades.",Nano-Computed Tomography (NanoCT),207
233,234,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Images were acquired immediately after staining at magnifications of 206 and 406 using a SPOT RT slider cooled CCD camera attached to an Olympus BX51 microscope.,Tartrate Resistant Acid Phosphatase (TRAP) Staining,225
233,235,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Images were acquired immediately after staining at magnifications of 206 and 406 using a SPOT RT slider cooled CCD camera attached to an Olympus BX51 microscope.,Tartrate Resistant Acid Phosphatase (TRAP) Staining,225
234,235,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Images were acquired immediately after staining at magnifications of 206 and 406 using a SPOT RT slider cooled CCD camera attached to an Olympus BX51 microscope.,Tartrate Resistant Acid Phosphatase (TRAP) Staining,225
236,240,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Total RNA was isolated from both RNAlater-fixed pelvic ilia (flushed of bone marrow) from spaceflight and ground control animals using the TRIzol method (Invitrogen).Briefly, ilia were homogenized with a hand held homogenizer in 1 ml of TRI",RNA Isolation and RT-qPCR Analysis,232
236,241,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Total RNA was isolated from both RNAlater-fixed pelvic ilia (flushed of bone marrow) from spaceflight and ground control animals using the TRIzol method (Invitrogen).Briefly, ilia were homogenized with a hand held homogenizer in 1 ml of TRI",RNA Isolation and RT-qPCR Analysis,232
240,241,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Total RNA was isolated from both RNAlater-fixed pelvic ilia (flushed of bone marrow) from spaceflight and ground control animals using the TRIzol method (Invitrogen).Briefly, ilia were homogenized with a hand held homogenizer in 1 ml of TRI",RNA Isolation and RT-qPCR Analysis,232
253,254,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
253,255,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
253,256,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
253,257,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
254,255,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
254,256,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
254,257,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
255,256,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
255,257,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
256,257,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Each array consisted of primer sets for 84 pathway-focused genes of interest, five reference genes (Gusb, Hprt1, Hsp90ab1, Gapdh, and Actb), one genomic DNA contamination control, three positive PCR controls and three positive reverse trans",RNA Isolation and RT-qPCR Analysis,238
279,280,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Real-time PCR conditions were as follows: one cycle 95uC for 10 min, 40 cycles of 95uC for 15 s and 60uC for 1 min, followed by one cycle of 95uC for 15 s, 60uC for 1 min, 95uC for 15 s and 60uC for 15 s.Gene expression levels from all arra",RNA Isolation and RT-qPCR Analysis,243
279,281,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Real-time PCR conditions were as follows: one cycle 95uC for 10 min, 40 cycles of 95uC for 15 s and 60uC for 1 min, followed by one cycle of 95uC for 15 s, 60uC for 1 min, 95uC for 15 s and 60uC for 15 s.Gene expression levels from all arra",RNA Isolation and RT-qPCR Analysis,243
280,281,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"Real-time PCR conditions were as follows: one cycle 95uC for 10 min, 40 cycles of 95uC for 15 s and 60uC for 1 min, followed by one cycle of 95uC for 15 s, 60uC for 1 min, 95uC for 15 s and 60uC for 15 s.Gene expression levels from all arra",RNA Isolation and RT-qPCR Analysis,243
283,284,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
283,288,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
283,290,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
283,291,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
284,288,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
284,290,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
284,291,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
288,290,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
288,291,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
290,291,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,"The following primary polyclonal antibodies were used in the immunohistocehmical analysis: anti-p21 (1:50 dilution, Santa Cruz Biotechnology), anti-p53 (1:50 dilution, Santa-Cruz Biotechnology), anti-Matrix Metallopeptidase 10 (1:20 dilutio",Immunohistochemical and Immunocytochemical Analysis,245
292,293,GENE_PRODUCT_INTERACTS_WITH_GENE_PRODUCT,COOC,,Sections were washed in PBS-T and incubated with peroxidase conjugated secondary antibody in a moist chamber at room temperature for 1 h and then rinsed with PBS-T and incubated in peroxidase substrate for 12-30 min until staining was compl,Immunohistochemical and Immunocytochemical Analysis,247
PUB_PMC3630201,1,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,7,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,27,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,47,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,52,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,59,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,62,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,64,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,88,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,89,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,93,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,97,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,116,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,121,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,124,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,128,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,130,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,131,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,136,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,138,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,140,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,141,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,147,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,148,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,159,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,160,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,163,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,165,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,166,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,171,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,189,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,190,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,191,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,192,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,194,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,196,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,200,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,201,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,206,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,212,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,217,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,218,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,225,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,228,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,229,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,230,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,237,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,238,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,244,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,245,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,246,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,247,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,248,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,249,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,250,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,251,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,259,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,261,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,263,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,264,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,265,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,266,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,269,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,271,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,272,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,274,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,275,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,277,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,286,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,295,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,296,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,297,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,301,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_LINK,,,,
PUB_PMC3630201,41,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,42,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,43,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,44,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,55,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,56,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,66,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,67,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,69,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,70,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,75,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,76,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,77,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,78,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,79,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,80,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,82,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,83,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,84,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,85,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,100,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,101,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,143,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,144,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,145,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,146,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,149,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,150,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,151,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,152,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,153,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,155,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,156,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,161,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,162,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,167,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,168,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,169,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,170,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,172,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,173,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,174,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,175,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,176,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,177,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,178,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,179,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,180,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,182,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,183,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,184,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,185,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,186,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,187,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,197,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,198,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,210,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,211,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,213,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,214,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,219,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,220,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,233,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,234,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,235,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,236,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,240,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,241,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,253,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,254,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,255,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,256,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,257,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,279,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,280,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,281,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,283,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,284,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,288,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,290,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,291,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,292,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
PUB_PMC3630201,293,PUBLICATION_EVIDENCES_ENTITY,PUBLICATION_CONNECTIVITY,,,,
